NASDAQ:SYRE | Key Financial Ratios | Spyre Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-3018.53-15.25%-16.25%
2026-03-318.97-23.49%-26.75%
2025-12-3113.25-19.95%-21.70%
2025-09-3010.9-29.52%-32.73%
2025-06-306.49-38.38%-45.38%
2025-03-318.06-36.67%-43.29%
2024-12-3111.26-34.19%-40.17%
2024-09-307.32-51.03%-65.64%
2024-06-3019.7-42.65%-49.68%
2024-03-3111.38-74.70%-239.20%
2023-12-3110.68-99.10%-184.11%
2023-09-304.59-142.06%119.98%
2023-06-301.03-111.92%131.44%
2023-03-313.51-148.33%-231.19%
2022-12-314.25-117.81%-166.61%
2022-09-304.65-93.31%-126.47%
2022-06-306.09-82.01%-103.99%
2022-03-314.45-86.59%-116.81%
2021-12-314.91-59.86%-78.39%
2021-09-305.75-52.74%-66.68%
2021-06-306.52-44.76%-55.28%
2021-03-314.68-49.13%-64.95%
2020-12-319.11-50.05%-57.85%
2020-09-3010.06-51.19%-58.47%
2020-06-3010.19-48.13%-54.65%
2020-03-313.17-123.21%-186.46%
2019-12-314.06-94.07%-130.25%
2019-09-306.02-71.59%-89.80%
2019-06-308.44-52.77%-62.24%
2019-03-3110.74-41.55%-45.92%
2018-12-317.49-57.05%-65.77%
2018-09-309.37-50.41%-56.43%
2018-06-3012.78-40.01%-43.42%
2018-03-318.47-58.47%-66.28%
2017-12-319.77-48.57%-54.11%
2017-09-3012.2-43.36%-47.27%
2017-06-3014.98-36.64%-39.29%
2017-03-3115.24-38.19%-40.92%
2016-12-3116.75-32.35%-34.46%
2016-09-3018.68-28.03%-29.62%
2016-06-3022.88-22.48%-23.51%
2016-03-319.22-37.63%50.26%
2015-12-3115.17-29.22%50.86%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-3113.25-19.95%-21.70%
2024-12-3111.26-34.19%-40.17%
2023-12-3110.68-99.10%-184.11%
2022-12-314.25-117.81%-166.61%
2021-12-314.91-59.86%-78.39%
2020-12-319.11-50.05%-57.85%
2019-12-314.06-94.07%-130.25%
2018-12-317.49-57.05%-65.77%
2017-12-319.77-48.57%-54.11%
2016-12-3116.75-32.35%-34.46%
2015-12-3115.17-29.22%50.86%
2014-12-3190.19%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.